News

Dr. Lee Hood Writes ‘Second Opinion’ Columns for Los Angeles Times

ISB Co-founder, Chief Strategy Officer and Professor Dr. Lee Hood is credited with coining the term “systems biology,” and has been a longtime advocate of P4 medicine (predictive, preventive, personalized and participatory).

Now, Hood has been selected by the Los Angeles Times to share his insights in a new weekly op-ed column, called Second Opinion.

The column “aims to engage cutting-edge debates about the unprecedented global challenges that our society faces” and “will feature contributions from thought leaders, scientists, diplomats, humanitarians, artists, economists, and other experts who will offer their insights into these challenges, in an effort to identify solutions and actions to solve them,” said Dr. Patrick Soon-Shiong, executive chairman of the L.A. Times, in an article announcing the weekly column.

Hood has penned two columns, and more are in the works. The Second Opinion columns are published in print in Sunday Los Angeles Times newspapers and appear on latimes.com. They are also syndicated by Yahoo News and many other outlets. Prior to the launch of Second Opinion, Hood and author Matthew LaPlante wrote an op-ed for the Los Angeles Times.

Dr. Hood’s Columns:

 

Claire Reid / Los Angeles Times; Getty Images, Unsplash

Image Courtesy Claire Reid / Los Angeles Times; Getty Images, Unsplash

Op-Ed: The key to treating Alzheimer’s disease may not be a drug
June 30, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Nicole Vas

Second Opinion: How long haul COVID could offer clues for treating other puzzling illnesses
April 18, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Science Photo Library / Associated Press

Second Opinion: Getting past disease to the science of wellness
March 21, 2021

Read more

Los Angeles Times Image

Image courtesy Los Angeles Times / Associated Press

Op-Ed: How science education can stave off demagogues
January 24, 2021

Read more

Recent Articles

  • Autoimmune Disease and Pregnancy: ISB Study Challenges Prevailing Wisdom, Unveils Nuances

    An ISB-led study showed nuanced pregnancy outcomes for pregnant individuals with autoimmune disease. The findings reinforce that there isn’t a one-size-fits-all approach, and provides important new avenues for further investigation.

  • ISB Building at dusk

    2023 Year in Review

    Throughout 2023, ISB research has been published in impactful peer-reviewed journals and our scientists have been featured in major media outlets and popular podcasts. In this 2023 Year in Review, we showcase some of our most important and interesting highlights of the year.

  • Lifestyle coaching improves cognitive decline in Alzheimer's disease trial.

    Personalized Coaching Decreases Cognitive Decline in Early-Stage Alzheimer’s Disease Patients

    Supplementing the standard of treatment for Alzheimer’s disease patients with personalized lifestyle coaching leads to less cognitive decline compared to standard of treatment alone, according to an ISB-led two-year study. The results were published in the Journal of Alzheimer’s Disease.